Vaxcyte, Inc. financial data

Symbol
PCVX on Nasdaq
Location
San Carlos, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 04 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1181% % -18%
Debt-to-equity 7.2% % 20%
Return On Equity -21% % 10%
Return On Assets -20% % 11%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 130,906,263 shares 5%
Common Stock, Shares, Outstanding 130,029,111 shares 4.5%
Entity Public Float $7,200,000,000 USD 76%
Common Stock, Value, Issued $133,000 USD 4.7%
Weighted Average Number of Shares Outstanding, Basic 136,196,512 shares 10%
Weighted Average Number of Shares Outstanding, Diluted 136,196,512 shares 10%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $685,860,000 USD 53%
General and Administrative Expense $125,701,000 USD 54%
Operating Income (Loss) $811,561,000 USD -34%
Nonoperating Income (Expense) $29,550,000 USD -20%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $657,201,000 USD -29%
Earnings Per Share, Basic -4 USD/shares -5%
Earnings Per Share, Diluted -4 USD/shares -5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $281,080,000 USD -73%
Other Assets, Current $4,456,000 USD 111%
Assets, Current $1,767,167,000 USD -20%
Property, Plant and Equipment, Net $253,486,000 USD 55%
Operating Lease, Right-of-Use Asset $83,515,000 USD 191%
Other Assets, Noncurrent $106,708,000 USD 78%
Assets $3,171,600,000 USD -11%
Accounts Payable, Current $48,962,000 USD 169%
Employee-related Liabilities, Current $16,762,000 USD 37%
Accrued Liabilities, Current $24,592,000 USD -20%
Liabilities, Current $200,046,000 USD 62%
Operating Lease, Liability, Noncurrent $78,672,000 USD 329%
Other Liabilities, Noncurrent $100,000 USD
Liabilities $278,718,000 USD 96%
Accumulated Other Comprehensive Income (Loss), Net of Tax $856,000 USD 516%
Retained Earnings (Accumulated Deficit) $1,908,440,000 USD -53%
Stockholders' Equity Attributable to Parent $2,892,882,000 USD -15%
Liabilities and Equity $3,171,600,000 USD -11%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $166,274,000 USD -4.5%
Net Cash Provided by (Used in) Financing Activities $759,000 USD -100%
Net Cash Provided by (Used in) Investing Activities $123,317,000 USD
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 130,029,111 shares 4.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $41,026,000 USD -119%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $282,548,000 USD -73%
Deferred Tax Assets, Valuation Allowance $446,098,000 USD 55%
Deferred Tax Assets, Gross $468,078,000 USD 57%
Operating Lease, Liability $84,443,000 USD 202%
Payments to Acquire Property, Plant, and Equipment $5,424,000 USD -4.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $656,484,000 USD -30%
Lessee, Operating Lease, Liability, to be Paid $118,027,000 USD 243%
Property, Plant and Equipment, Gross $214,319,000 USD 141%
Operating Lease, Liability, Current $5,771,000 USD -40%
Lessee, Operating Lease, Liability, to be Paid, Year Two $10,826,000 USD 154%
Lessee, Operating Lease, Liability, to be Paid, Year One $11,861,000 USD -5.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure -12%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $33,584,000 USD 420%
Lessee, Operating Lease, Liability, to be Paid, Year Three $11,824,000 USD 296%
Deferred Tax Assets, Operating Loss Carryforwards $195,869,000 USD 45%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $9,525,000 USD 114%
Lessee, Operating Lease, Liability, to be Paid, Year Four $12,178,000 USD 296%
Operating Lease, Payments $12,448,000 USD 16%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $2,956,000 USD 196%
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%